A marked increase in catecholamines and endorphins at birth has been described in animals and man. Because the factors which regulate catecholamine secretion are incompletely understood and because it has been suggested that endogenous opiates are important in the regulation of catecholamine secretion, we designed studies to compare changes in plasma catecholamines at birth with simultaneously measured endorphins. Catecholamines and ß-endorphin-like immunoreactivity (ß-ELI) were measured at birth in term(145 days) and preterm (130 days) lambs. Preterm lambs were given natural sheep surfactant intratracheally to prevent respiration failure. Following umbilical cord cutting, there was a marked increase in circulating norepinephrine (NE) and epinephrine (E) levels. The peak preterm NE (2.2 ± 0.3 ng/ml at 1 h) was greater than the peak term NE (1.0 ± 0.2 ng/ml at 5 min). The peak preterm E occurred later and also was greater than the peak term E (4.0 ±0.5 ng/ml at 1 h vs. 1.3 ± 0.4 ng/ml at 15 min, respectively, p < 0.01). Baseline ß-ELI in term animals (767 ± 15 pg/ml) was greater than preterm (456 ± 12 pg/ml). Following cord cutting peak ß-ELI in term animals rose to 867 ± 201 pg/ml compared to a peak ß-ELI in preterm animals of 1,866 ± 450 pg/ml. These results and their significance for neonatal adaptation to extrauterine life are discussed.

Keywords:
Delivery, Newborn, Catecholamines, Endorphins
This content is only available via PDF.
1988
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.